Supplementary
, the panadenosine receptor antagonist CGS15943 (5 µM, n = 7), the A 1 antagonist PSB36 (0.1 µM, n = 5), the A 3 antagonist MRS3777 (0.1 µM, n = 5), the A 2A antagonist ZM241385 (100 µM, n = 7) or the A 2B antagonist PSB603 (0.1 µM, n = 7) had no effect on the frequency of SA at low (A) or high (B) frequency ranges. Data are presented as mean ± SEM. RT-PCR analysis demonstrated no difference in A 2A or A 2B mRNA levels in mucosa from control or SCI rats. In bladder strips from which mucosa was removed, levels of A 2B were higher than those of A 2A in both control and SCI rats, but levels of both receptors were similar between tissues from control and SCI rats. Data are presented as mean ± SD of 1/∆Ct values. The amplitude of SA at both low (A) and high (B) frequency was significantly reduced by inosine (1 mM; n=14). However, the inhibitory effect of inosine on SA was not blocked by the ENT1 specific inhibitor NBMPR (10 µM, n=10). Inosine did not affect the frequency of SA under baseline conditions or after NBMPR treatment (right panels). Data are presented as mean ± SEM.
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